Home Healthcare Healthcare Services Terminal Sterilization Services Market

Terminal Sterilization Services Market Size, Share & Trends Analysis Report By Product (Ethylene Oxide, Irradiation, Moist Heat Terminal sterilization, Others), By End Use (Hospitals & Clinics, Pharma, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:

Terminal Sterilization Services Market Size

The global terminal sterilization services market size was valued at USD 14.29 billion in 2025 and is projected to grow from USD 15.85 billion in 2026 to USD 36.35 billion by 2034, registering a CAGR of 10.93% during the forecast period from 2026 to 2034. North America dominated the terminal sterilization services market with a market share of 38.4% in 2025.

Terminal sterilization is the method of sterilizing a product in its final container. It is an essential procedure because it assures that the product remains sterile. All parenteral, ophthalmic, and medical equipment is usually sterilized using heat in batches. An alternative method, such as filtration, is used, which reduces the risk of a product becoming contaminated because the heat may cause damage to the products. The increasing prominence of chronic diseases like diabetes and cancer, the increasing prevalence of hospital-acquired infections, and new product launches by the key market players are factors driving the terminal sterilization services market growth.

Terminal Sterilization Services Market Size

Download a Free Sample To learn more about this report.

Product Insights

The global market has been segmented into ethylene oxide, irradiation, moist heat terminal sterilization, and others. Among these, the ethylene oxide segment accounted for the largest market share and is estimated to grow at a CAGR of 10.5% during the forecast period. This sterilization technique is used as an alternative to steam/dry heat for sterilizing moisture-intolerant or heat-sensitive surgical equipment & supplies in healthcare facilities. Items and devices, such as electrical devices, plastics wares, & corrosion-susceptible instruments that cannot endure extreme temperature and humidity, can be treated by this technique, as this technique is compatible with most medical devices and materials. Therefore, the increasing need for sterilization of heat- and moisture-sensitive medical equipment with complex designs is propelling the need for ETO sterilization, contributing to the growth of this segment over the forecast period.

The moist heat terminal sterilization segment is expected to grow at the highest CAGR during the forecast period. Steam/moist heat sterilization is carried out in an autoclave that produces pressurized steam. The intense heat causes coagulation & hydrolysis of proteins, killing microbes, viruses, and spores. Autoclaves usually expose the product to steam at a temperature of 121–134°C (250–273°F) for 15–30 minutes. As the pressure and temperature increase, the time required to sterilize items reduces. This method is widely used in heat sterilization to achieve sterility of medical equipment and devices. It does not involve toxic fumes or liquids, and it is quick & effective in killing & eliminating infectious bacteria, viruses, & spores. Moist heat sterilization is widely used in all hospitals to disinfect medical equipment, such as surgical scalpels. Dentists frequently use this technique to sterilize dental equipment. Thus, the abovementioned factors are expected to boost the market over the forecast period.

Terminal Sterilization Services Market Size By Segments

Request Customizationto receive a tailored report.

End User Insights

The global market is segmented into hospitals & clinics, pharma, and others. The hospitals and clinic segment accounted for the largest market share and is estimated to grow at a CAGR of 10.5% during the forecast period. Increases in R&D and the introduction of complex equipment & devices are boosting demand for sterilization procedures in pharmaceutical companies. Complex medical devices require effective sterilization techniques, as traditional methods might not assure complete sterility, propelling demand for advanced equipment. The increased need for sterilization of manufacturing equipment and packages has led to advancements in terminal sterilization techniques for pharmaceutical companies. In addition, FDA regulations and guidelines for pharmaceutical preparations are other significant factors boosting the adoption of advanced & effective sterilization methods, such as sterilization through X-rays & gamma rays. Moreover, the growing focus on developing vaccines to tackle the pandemic by pharma & biotech companies has increased the demand for sterilization equipment. These factors are responsible for the growth of this segment in the market.

The hospitals and clinics segment is expected to grow at the highest CAGR during the forecast period. The increasing burden of HAIs primarily boosts the demand for sterilization in hospitals and other healthcare settings. In addition, a growing number of surgical procedures and stringent safety guidelines for staff & patients in terms of medical waste disposal are likely to drive the adoption of sterilization in hospitals. Using suitable disinfectants and sterilization methods is essential, as they can help prevent the transmission of infections. In addition, a rise in healthcare expenditure in developing economies is likely to boost the number of hospitals, owing to which demand for sterilization services is expected to increase over the forecast period. For instance, according to WHO, in Brazil, total healthcare expenditure was 9.1% of its GDP in 2016. Furthermore, according to the World Bank estimates, in 2016, public & private healthcare spending accounted for 8.5% of the total GDP in Brazil. Such factors are expected to propel the segment over the forecast period.

Terminal Sterilization Services Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America accounted for the largest market share and is estimated to grow at a CAGR of 10.4% during the forecast period. North America dominated the terminal sterilization services market with the largest share owing to government initiatives and increasing surgeries. Furthermore, the increase in chronic disease prevalence and disposable income contribute to the market growth in the region. The growing incidence of HAIs and the increasing number of surgeries are anticipated to boost the demand for terminal sterilization services in the U.S. For instance, as per Healthcare Information and Management Systems Society, each day, 1 out of 25 patients in the U.S. is affected by HAIs. Proper and regular usage of antiseptics, disinfectants, terminal sterilization of devices, and surgical equipment in hospitals & clinics generally helps prevent such infections, as these steps reduce or kill harmful microbes & bacteria, creating an aseptic environment. Thus, the increasing prevalence of HAIs is expected to boost the demand for terminal sterilization. In addition, the rising number of surgeries in the U.S. is expected to boost the market, as terminal sterilization plays an essential role in reprocessing surgical units. For instance, per the American Society for Aesthetic Plastic Surgery, surgical procedures accounted for 77% of total expenditure in 2017 in the U.S. These factors are expected to impact the market over the forecast period positively.

North America Terminal Sterilization Services Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Terminal Sterilization Services Market Trends

The Europe terminal sterilization services market is the second largest and is estimated to reach an expected value of USD 5470 million at a CAGR of 10.5% during the forecast period. A growing number of surgeries and increasing incidence of HAIs are expected to fuel the market over the forecast period. For instance, as per ECDC estimates, around 3.1-4.6 million people acquire HAIs in Europe every year. Major market players are undertaking various initiatives for the sterilization of equipment & medical devices, and recommendations by doctors for using such solutions are also anticipated to propel the market. In addition, the increasing number of surgical procedures being performed is likely to impact the market growth positively, as usage of terminal sterilization is necessary for reprocessing the surgical devices & equipment before surgeries. Furthermore, the COVID-19 pandemic has increased the regional demand for terminal sterilization services.

Asia Pacific exhibited the highest CAGR during the forecast period due to the increased number of hospitals and healthcare spending. The increasing incidence of HAIs and chronic diseases is a significant factor driving the market over the forecast period. In addition, growing awareness about new technologies for sterilizing medical devices, equipment, and other products will likely impact the market positively. Furthermore, major players are undertaking efforts to enter untapped markets in the Asia Pacific, thereby expanding the market scope.

List of Key and Emerging Players in Terminal Sterilization Services Market

Steris Plc
3M
Getinge AB
ASP (Fortive)
Cantel Medical
Matachana Group
Sterigenics U.S. LLC (Soltera Health Company)
Olympus Corporation
BelimedInc.(Metall Zug Group)
TSO3 (Stryker Corporation)

Key Industry Developments

April 2026
STERIS expanded its global contract sterilization network by opening a new gamma irradiation facility, increasing capacity for terminal sterilization of medical devices and healthcare products.
January 2026
Sotera Health expanded electron beam sterilization capacity at its Sterigenics facilities to support growing demand for terminal sterilization services for medical devices and pharmaceutical products.
June 2025
Sterigenics completed expansion projects at multiple sterilization facilities to increase gamma irradiation and EtO processing capacity for healthcare manufacturers.

Report Scope

Segmentation

By Product 4
  • Ethylene Oxide
  • Irradiation
  • Moist Heat Terminal sterilization
  • Others
By End Use 3
  • Hospitals & Clinics
  • Pharma
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Steris Plc · 3M · Getinge AB · ASP (Fortive) · Cantel Medical
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The terminal sterilization services market size is valued at USD 15.85 Billion in 2026 and is projected to reach USD 36.35 Billion by 2034, at a CAGR of 10.93% during the forecast period 2026-2034.
North America dominated the market with a share of 38.4% in 2025.
The leading players in this market are Steris Plc, 3M, Getinge AB, ASP, Cantel Medical.
The terminal sterilization services market is projected to grow at a CAGR of 10.93% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now